A Long Island hospital has said that it has successfully eliminated sickle cell disease from Sebastien Beauzile, a 21-year-old from Laurelton, using the groundbreaking Lyfgenia gene therapy. Cohen ...

Learn the essential early warning signs of leukemia that are often dismissed as everyday ailments but could be indicators of ...

Lan Coffman, M.D., Ph.D., associate professor of malignant hematology and medical oncology in the University of Pittsburgh School of Medicine and member of Magee-Womens Research Institute and UPMC Hil ...

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

March is Colorectal Cancer Awareness Month, and New York Oncology Hematology is raising awareness about the importance of getting screened early.The organization is holding a fundraising event on ...

Amgen (AMGN) is a biotech company based in California. It specializes in developing treatments for cardiovascular conditions, oncology, hematology, neurology, bone health, nephrology, and more.

People with the rare Li-Fraumeni syndrome (LFS) have a high risk of developing cancer. Almost all those affected will develop ...

In this episode of Targeted Talks, Alfred L. Garfall, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, ...

Nature's Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the founding of its Scientific Advisory Board (SAB) with ...

Bionano Genomics (BNGO) announced a study published in the American Journal of Hematology demonstrating the potential utility of optical genome ...

When Jennifer Woyach, MD, started as a resident and fellow two decades ago, patients with chronic lymphocytic leukemia (CLL) ...